Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Flea treatment recalled over labelling error
The VMD has issued a product defect recall alert for a single batch of Johnson's 4Fleas 80mg Spot-on solution for Cats.
Recall concerns single batch of Johnson’s 4Fleas 80mg Spot-on Solution for Cats.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Johnson’s 4Fleas 80mg Spot-on Solution for Cats, manufactured by Johnson’s Veterinary Products Ltd.

In a press release, the VMD reports that the treatment was being recalled owing to a labelling error.

On the leaflet provided in the box, it states: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats of less than 4 kg bodyweight.'

However, the leaflet should state: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats greater or equal to 4 kg bodyweight.'

The recall affects only a single batch – DO41 Johnson's 4Fleas Large Cat 6X2X0.8ml – KP0F3U7

The VMD writes: 'Johnson’s Veterinary Products Ltd is contacting wholesale dealers to examine inventory immediately and quarantine products subject to this recall. This issue only applies to the batch listed above. Any other batches of Johnson’s 4Fleas 80mg Spot-on Solution for Cats are not impacted and may continue to be distributed.'

For further details about the recall contact Grant Exall, quality assurance/WQP, email: Grantexall@johnsons-vet.com, or Nick Franks, sales director, email Nickfranks@johnsons-vet.com, or Tel: 0121 378 1684.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.